Juan Miguel Sanchez Nieto

Dr. Juan Miguel Sanchez Nieto

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2023 in Cells
Verified
Journal Article
Open access
PDF file
GMGracia Mendoza
Gracia Mendoza
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
JNJuan Miguel Sanchez Nieto
Juan Miguel Sanchez Nieto
AAAltamira Arce-Cerezo
Altamira Arce-Cerezo
MQMiguel Quintanilla
Miguel Quintanilla
PMPilar Martin-Duque
Pilar Martin-Duque
The induction of pluripotency by enforced expression of different sets of genes in somatic cells has been achieved with reprogramming technologies first described by Yamanaka’s group. Methodologies for generating induced pluripotent stem cells are as varied as the combinations of genes used. It has previously been reported that the adenoviral E1a gene can induce the expression of two of the Yamanaka factors (c-Myc and Oct-4) and epigenetic changes. Here, we demonstrate that the E1a-12S over-expression is sufficient to induce pluripotent-like characteristics closely to epiblast stem cells in mouse embryonic fibroblasts through the activation of the pluripotency gene regulatory network. These findings provide not only empirical evidence that the expression of one single factor is sufficient for partial reprogramming but also a potential mechanistic explanation for how viral infection could lead to neoplasia if they are surrounded by the appropriate environment or the right medium, as happens with the tumorogenic niche.

28 July 2023 in Cells
Verified
Journal Article
Open access
PDF file
KRKimberley Great Ormond Street Institute of Child Health – Zayed Centre for Rare Disease in Reid
Kimberley Great Ormond Street Institute of Child Health – Zayed Centre for Rare Disease in Reid
JNJuan Miguel Sanchez Nieto
Juan Miguel Sanchez Nieto
STSandra Terrasse
Sandra Terrasse
DFDanilo Faccenda
Danilo Faccenda
BPBarbara Pernaute
Barbara Pernaute
BCBradley Cobb
Bradley Cobb
MicroRNAs (miRNAs) are important regulators of embryonic stem cell (ESC) biology, and their study has identified key regulatory mechanisms. To find novel pathways regulated by miRNAs in ESCs, we undertook a bioinformatics analysis of gene pathways differently expressed in the absence of miRNAs due to the deletion of Dicer, which encodes an RNase that is essential for the synthesis of miRNAs. One pathway that stood out was Ca2+ signaling. Interestingly, we found that Dicer−/− ESCs had no difference in basal cytoplasmic Ca2+ levels but were hyperresponsive when Ca2+ import into the endoplasmic reticulum (ER) was blocked by thapsigargin. Remarkably, the increased Ca2+ response to thapsigargin in ESCs resulted in almost no increase in apoptosis and no differences in stress response pathways, despite the importance of miRNAs in the stress response of other cell types. The increased Ca2+ response in Dicer−/− ESCs was also observed during purinergic receptor activation, demonstrating a physiological role for the miRNA regulation of Ca2+ signaling pathways. In examining the mechanism of increased Ca2+ responsiveness to thapsigargin, neither store-operated Ca2+ entry nor Ca2+ clearance mechanisms from the cytoplasm appeared to be involved. Rather, it appeared to involve an increase in the expression of one isoform of the IP3 receptors (Itpr2). miRNA regulation of Itpr2 expression primarily appeared to be indirect, with transcriptional regulation playing a major role. Therefore, the miRNA regulation of Itpr2 expression offers a unique mechanism to regulate Ca2+ signaling pathways in the physiology of pluripotent stem cells.